Buffington Mohr McNeal’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$440K Sell
2,655
-1,412
-35% -$221K 0.09% 74
2024
Q4
$588K Buy
4,067
+375
+10% +$58.1K 0.1% 85
2024
Q3
$598K Sell
3,692
-147
-4% -$23.4K 0.1% 87
2024
Q2
$561K Sell
3,839
-50
-1% -$7.44K 0.1% 88
2024
Q1
$615K Sell
3,889
-23
-0.6% -$3.66K 0.11% 85
2023
Q4
$613K Sell
3,912
-366
-9% -$56.1K 0.12% 78
2023
Q3
$666K Sell
4,278
-4,565
-52% -$753K 0.15% 80
2023
Q2
$1.46M Buy
8,843
+252
+3% +$40.7K 0.32% 49
2023
Q1
$1.33M Sell
8,591
-5
-0.1% -$807 0.31% 50
2022
Q4
$1.52M Sell
8,596
-310
-3% -$53.5K 0.35% 49
2022
Q3
$1.46M Sell
8,906
-798
-8% -$135K 0.35% 48
2022
Q2
$1.72M Buy
9,704
+128
+1% +$22.8K 0.38% 48
2022
Q1
$1.7M Sell
9,576
-2,100
-18% -$357K 0.32% 53
2021
Q4
$2M Sell
11,676
-3,807
-25% -$623K 0.34% 49
2021
Q3
$2.5M Buy
15,483
+361
+2% +$61.6K 0.48% 46
2021
Q2
$2.49M Sell
15,122
-595
-4% -$98.5K 0.49% 46
2021
Q1
$2.58M Buy
15,717
+189
+1% +$30.6K 0.55% 43
2020
Q4
$2.44M Buy
15,528
+238
+2% +$35.1K 0.57% 39
2020
Q3
$2.28M Sell
15,290
-1,176
-7% -$174K 0.6% 36
2020
Q2
$2.32M Sell
16,466
-195
-1% -$28.4K 0.65% 40
2020
Q1
$2.19M Sell
16,661
-748
-4% -$106K 0.73% 37
2019
Q4
$2.54M Sell
17,409
-4,430
-20% -$601K 0.72% 39
2019
Q3
$2.83M Sell
21,839
-520
-2% -$68.5K 0.86% 33
2019
Q2
$3.11M Sell
22,359
-261
-1% -$36.1K 0.97% 35
2019
Q1
$3.16M Buy
22,620
+59
+0.3% +$7.9K 1.02% 32
2018
Q4
$2.91M Buy
22,561
+125
+0.6% +$17.4K 1.17% 28
2018
Q3
$3.1M Buy
22,436
+250
+1% +$33.2K 1.07% 32
2018
Q2
$2.69M Sell
22,186
-10,901
-33% -$1.36M 1.01% 33
2018
Q1
$4.24M Buy
33,087
+180
+0.5% +$24.3K 1.62% 21
2017
Q4
$4.6M Sell
32,907
-550
-2% -$76.6K 1.76% 19
2017
Q3
$4.74M Sell
33,457
-1,030
-3% -$137K 1.84% 17
2017
Q2
$4.56M Buy
34,487
+1,303
+4% +$166K 1.8% 16
2017
Q1
$4.13M Sell
33,184
-802
-2% -$95.8K 1.82% 14
2016
Q4
$3.92M Sell
33,986
-622
-2% -$71.8K 1.5% 18
2016
Q3
$4.09M Buy
34,608
+495
+1% +$60.1K 1.72% 14
2016
Q2
$4.14M Sell
34,113
-4,150
-11% -$472K 1.82% 13
2016
Q1
$4.14M Buy
38,263
+6,871
+22% +$711K 1.82% 14
2015
Q4
$3.23M Buy
31,392
+3,200
+11% +$322K 1.73% 14
2015
Q3
$2.63M Sell
28,192
-310
-1% -$30K 1.72% 16
2015
Q2
$2.78M Sell
28,502
-547
-2% -$54.8K 1.54% 16
2015
Q1
$2.92M Sell
29,049
-421
-1% -$42.8K 1.62% 17
2014
Q4
$3.08M Sell
29,470
-625
-2% -$65.9K 1.77% 16
2014
Q3
$3.21M Sell
30,095
-2,771
-8% -$287K 1.82% 15
2014
Q2
$3.44M Sell
32,866
-95
-0.3% -$9.6K 1.9% 15
2014
Q1
$3.24M Sell
32,961
-55
-0.2% -$5.1K 1.94% 14
2013
Q4
$3.02M Sell
33,016
-850
-3% -$78.3K 1.86% 14
2013
Q3
$2.94M Sell
33,866
-471
-1% -$42.3K 1.84% 12
2013
Q2
$2.95M Buy
+34,337
New +$2.91M 1.96% 11

Other funds holding JNJ

Buffington Mohr McNeal's JNJ Position: Q1 2025 in Review

Buffington Mohr McNeal reduced its Johnson & Johnson (JNJ) stake by 35% in Q1 2025, selling an estimated $221K and leaving 2,655 shares worth $440K. The position accounts for 0.09% of the portfolio, ranked #74.

Buffington Mohr McNeal first reported a position in JNJ in Q2 2013 and has held it in 48 quarters since. The position peaked at $4.74M in Q3 2017. 4,148 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

  • Buffington Mohr McNeal held 2,655 shares of Johnson & Johnson worth $440K as of Q1 2025.
  • Buffington Mohr McNeal sold 1,412 Johnson & Johnson shares in Q1 2025, an estimated $221K.
  • Johnson & Johnson made up 0.09% of Buffington Mohr McNeal's portfolio in Q1 2025, its #74 holding.
  • Buffington Mohr McNeal first reported a position in Johnson & Johnson in Q2 2013 and has held it in 48 quarters since.
  • Buffington Mohr McNeal's Johnson & Johnson position peaked at $4.74M in Q3 2017.
  • 4,148 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Buffington Mohr McNeal's 13F filing for Q1 2025, filed 28 Apr 2025.